IDEXX Labs beats estimates, raises guidance as stock gains
Alpha Vantage · Yahoo Finance · · AI-summarised by FinFlash
IDEXX Laboratories Inc. reported strong third-quarter results, exceeding analyst expectations for both earnings per share and revenue. The company also raised its full-year 2026 revenue and EPS guidance, leading to a 2.57% gain in pre-market trading. Key drivers included robust CAG Diagnostics recurring revenue growth and significant placements of IDEXX inVue Dx analyzers.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.